Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag exchanges : Amex save search
Atopic Dermatitis Drugs Market to grow by USD 4.7 billion from 2022-2027 | North America to account for 36% of market growth- Technavio
Published: 2023-10-17 (Crawled : 05:00) - prnewswire.com
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -0.27%
H: 1.38%
C: 0.83%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: -0.95%
H: 1.81%
C: 0.53%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.2%
H: 0.44%
C: -0.56%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
PHGE | $0.3274 -5.51% 3.82% 130K
|
Health Technology
|
| O: 5.0%
H: 3.17%
C: -1.56%
america dermatitis market
The Worldwide Diabetic Retinopathy Industry is Expected to Reach $7.7 Billion by 2027 at a 11.3% CAGR
Published: 2022-11-22 (Crawled : 13:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.33%
H: 1.88%
C: 1.53%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.77%
H: 0.41%
C: 0.27%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.66%
H: 0.79%
C: 0.72%
ALIM | $3.6 0.28% 0.28% 7.7K
|
Health Technology
|
| O: 0.47%
H: 7.5%
C: -1.17%
expected diabetic
Worldwide Radiotheranostics Industry to 2027 - By Radioisotope, Application, End-user, Competitive Landscape and Region
Published: 2022-11-09 (Crawled : 20:00) - prnewswire.com
TRUMF | $16.608 -17.59% 5.6K
|
Health Technology
|
| O: 2.88%
H: 1.93%
C: -0.99%
TRUMY | $17.05 0.79% 47K
|
Manufacturing
|
| O: 0.27%
H: 3.27%
C: 3.27%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: 3.26%
H: 1.01%
C: 0.76%
YMAB | $15.26 -0.52% -0.52% 160K
|
Health Technology
|
| O: 4.96%
H: 9.22%
C: 9.22%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 5.57%
H: 9.88%
C: 7.49%
ATNM | $7.06 1.44% 0.0% 150K
|
Health Technology
|
| O: 3.4%
H: 3.63%
C: 2.25%
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT2606, a Proposed Biosimilar of Nucala® (mepolizumab) Bio-Thera Solutions, Ltd. announced that dosing has begun in a Phase I cli...
Published: 2022-10-14 (Crawled : 13:00) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.17%
H: 0.8%
C: -0.75%
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -2.63%
H: 2.37%
C: -2.5%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.93%
H: 0.0%
C: 0.0%
DVA | News | $132.74 -0.87% 0.0% 470K
|
Health Services
|
| O: 0.65%
H: 1.88%
C: -0.77%
VRNA | $15.21 -2.44% -2.5% 320K
|
Health Technology
|
| O: 0.4%
H: 1.39%
C: -0.3%
UTHR | $237.06 1.11% 1.09% 610K
|
Health Technology
|
| O: 0.24%
H: 1.71%
C: 1.01%
NNVC | $1.15 0.88% 0.0% 14K
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: 0.0%
bat2606 nucala solutions biosimilar study
Head and Neck Cancer Market worth $ 9.07 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-23 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 3.81%
H: 0.0%
C: -0.44%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -4.55%
H: 6.28%
C: 6.28%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -1.94%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: 0.0%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: 0.0%
MGNX | $15.7 -3.27% -3.38% 520K
|
Health Technology
|
| O: -1.31%
H: 3.88%
C: -0.67%
KURA | News | $18.76 0.16% 0.16% 670K
|
Health Technology
|
| O: -1.34%
H: 0.12%
C: -2.6%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 0.04%
H: 0.08%
C: -1.26%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.31%
H: 1.85%
C: 1.55%
ADXS | $0.54 12.48% 950
|
Health Technology
|
| O: -1.64%
H: 8.33%
C: 0.0%
CVM | $1.46 -0.68% 0.0% 76K
|
Health Technology
|
| O: -0.92%
H: 2.31%
C: -3.47%
report cancer market
AavantiBio Announces Formation of Scientific Advisory Board
Published: 2022-02-09 (Crawled : 14:00) - biospace.com/
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
IBIO | $1.9 0.0% 99K
|
Health Technology
|
| O: 2.98%
H: 0.0%
C: 0.0%
ces
AavantiBio Further Enhances Leadership Team with Appointment of Jenny Marlowe, Ph.D. as Chief Scientific Officer
Published: 2021-11-16 (Crawled : 14:00) - biospace.com/
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.05%
H: 0.14%
C: -0.82%
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
IBIO | $1.9 0.0% 99K
|
Health Technology
|
| O: -6.01%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.